MAYopia Day - Session 2 - Repeated low-level red light therapy – shining the light on myopia
When:
Time:
Where: online
Interactive CPD points: 1
Clinical interest in myopia continues to grow with an increasing range of options available to manage its progression and help mitigate for the risks associated with the condition.
This event offers a full day of education delivered by experts from around the world offering key insights on the evidence-based management of myopia in clinical practice.
The programme has seven live webinars, each offering one interactive CPD point. Delegates are invited to attend the full programme or choose individual sessions based upon their clinical interests.
Session one: Driving change to put the brakes on myopia
Session two: Repeated low-level red light therapy – shining the light on myopia
Session three: A patient-centred approach to myopia management – what’s changed in the last 12 months?
Session four: The next generation – myopia controlling spectacle lenses
Session five: Communicating with patients and monitoring the progression of myopia in optometric practice
Session six: Busting the myopia myths
Session seven: Science of compliance – the importance of a flexible approach to managing myopia
Session two: Repeated low-level red light therapy – shining the light on myopia
Repeated low-level red-light therapy has been proposed as a new method to control myopia progression. It is delivered by an at-home desktop device, emitting red light through a semiconductor laser diode, under parental supervision. This webinar will present the most up-to-date information on the treatment, evidence on clinical efficacy and safety, as well as possible mechanism of the therapy.
Learning outcomes
- Practitioners will be able to explain to patients about the role of red light therapy for myopia management
- Practitioners will develop an understanding of the method, efficacy and safety of red light therapy for myopia management
10.15AM - 11.15AM
-
1 point
Webinar: Repeated low-level red light therapy - shining the light on myopia
CPD ref no: C-104824
Interactive:
Practitioner type:
Domains:
Professor Mingguang He
Professor Mingguang He is professor of ophthalmic epidemiology at the University of Melbourne. He undertook his medical training in China and holds a master’s in public health from Johns Hopkins University in Baltimore and a PhD in ophthalmology from Moorfields Eye Hospital.
Professor He is a global expert in vision-related clinical and epidemiologic research. He has led a series of important epidemiological studies and clinical trials, including the first population-based study on myopia in China, the first population-based study on glaucoma in China, a clinical trial to prove the efficacy of increased outdoor time on myopia prevention and a prophylactic clinical trial on angle closure glaucoma published in the Lancet 2019. His publications have attracted more than 13K citations.
He has received over $10m in major research grants in Australia, including the prestigious NHMRC investigator grant and Medical Research Future Fund for his research on artificial intelligence.
He founded and served as the first president of the Asia Pacific Tele-Ophthalmology Society and is a founding council member of Asia Pacific Myopia Society and deputy secretary-general for Asia Pacific Academy of Ophthalmology.